• Celldex Therapeutics (NASDAQ:CLDX) Receives Overweight Rating from Cantor Fitzgerald

    المصدر: Buzz FX / 29 يناير 2025 09:31:18   America/Chicago


    Celldex Therapeutics (NASDAQ:CLDX) Receives Overweight Rating from Cantor Fitzgerald Written by MarketBeat January 29, 2025 Share Link copied to clipboard. Celldex Therapeutics ( NASDAQ:CLDX - Get Free Report ) 's stock had its "overweight"
    Read more...
شارك على،